Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Clinical trial NCT00948064 · COMPLETED
Trial details
- NCT number
- NCT00948064
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-08
- Primary completion
- 2015-04-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.